发明名称 |
TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND FAMPRIDINE. |
摘要 |
This invention provides a method of treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising administering to the subject fampridine as an add-on therapy to or in combination with laquinimod. This invention also provides a package comprising laquinimod and fampridine for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention also provides fampridine for use as an add-on therapy or in combination with laquinimod in treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention also provides a pharmaceutical composition comprising laquinimod and fampridine for use in treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention further provides use of laquinimod and fampridine in the preparation of a combination for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. |
申请公布号 |
MX2015000485(A) |
申请公布日期 |
2015.04.08 |
申请号 |
MX20150000485 |
申请日期 |
2013.07.11 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. |
发明人 |
NORA TARCIC;JOEL KAYE |
分类号 |
A61P25/02;A01N43/42;A01N45/00 |
主分类号 |
A61P25/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|